FOOD AND DRUG ADMINISTRATION - CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
The Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) regulates biological products, including blood and blood products, blood derivatives, vaccines, allergenics, gene therapies, cellular therapies, and xenotransplantation, certain drug products, HIV test kits, medical devices involving blood and human cells and tissue products.